Bioveta Caniverm 175 mg 1 tab

Bioveta Caniverm worming tablet for puppies and kittens up to 2.5 kg 0.175 g

Composition:
1 tablet – 0.7 g contains:
Fenbendazole 150 mg, Pyrantel embonate 144 mg, Praziquantel 50 mg.

1 tablet – 0.175 g contains:
Fenbendazole 37.5 mg, Pyrantel embonate 36 mg, Praziquantel 12.5 mg.

Pharmacological action:
Caniverm has a broad spectrum of antiparasitic action against all developmental stages of roundworms and tapeworms, including: Toxocara canis, Toxocara cati, Toxascaris leonina, Uncinaria stenocephala, Ancylostoma caninum, Trichuris vulpis, Echinococcus granulosus, Dipylidium caninum, Taenia spp., Multiceps multiceps, Mesocestoides spp., Echinococcus multilocularis. Its mechanism of action is based on inhibiting the parasite's enzymes and damaging its outer layer and muscle tissue, which disrupts neuromuscular innervation and leads to paralysis and death of the helminth. Caniverm has low toxicity for warm-blooded animals.

Indications:
Caniverm is intended for the treatment and prevention of nematodoses (toxocariasis, toxascariasis, uncinariasis, ancylostomiasis, trichuriasis) and cestodoses (taeniasis, echinococcosis, dipylidiasis) in dogs and cats.

Administration and dosage:
The tablets are given orally once: whole, crushed or hidden in food. Do not give together with dairy food.
Puppies, small dog breeds and cats:

• 1 tablet 0.175 g per 0.5 - 2 kg of body weight
• 1 tablet 0.7 g or 2 tablets 0.175 g per 2 - 5 kg of body weight.

Medium-sized dogs:

• 1 tablet 0.7 g or 4 tablets 0.175 g per 5-10 kg of body weight.

Large dogs:

• 1 tablet for every started 10 kg of body weight.

Deworming of puppies and kittens is recommended once between 3 and 12 weeks of age at 3-week intervals, and every 3 months thereafter.

Adverse effects:
Within a few hours after administration, loose stools, a rash and in some cases a raised temperature may occur. This is a reaction to proteins released by dying worms, not a reaction to the medicine. The product may cause drowsiness.

Contraindications:
Ocular cysticercosis and spinal neurocysticercosis. Liver diseases.

Compatibility:
Do not use simultaneously with piperazine or other antiparasitic products.

Storage conditions:
In a dry, dark place, in undamaged, tightly closed original packaging, at a temperature of up to 25 °C.

Note:
When used in pregnant bitches, the exact dosage must be observed. In case of adverse effects, consult a veterinarian. The product must not be used in animals showing signs of other diseases.